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Abstract 1 
Purpose: While some microorganisms, such as Staphylococcus aureus, are clearly 2 
implicated in causing tissue damage in diabetic foot ulcers (DFUs), our knowledge of 3 
the contribution of the entire microbiome to clinical outcomes is limited. We profiled 4 
the microbiome of a longitudinal sample series of 28 people with diabetes and DFUs 5 
of the heel in an attempt to better characterise the relationship between healing, 6 
infection and the microbiome. 7 
 8 
Methodology: 237 samples were analysed from 28 DFUs, collected at fortnightly 9 
intervals for six months or until healing. Microbiome profiles were generated by 16S 10 
rRNA analysis, supplemented by targeted nanopore sequencing. 11 
 12 
Results/Key findings: DFUs which failed to heal during the study period (20/28, 13 
71.4%) were more likely to be persistently colonised with a heterogeneous community 14 
of microorganisms including anaerobes and Enterobacteriaceae (log-likelihood ratio 15 
9.56, p=0.008). During clinically apparent infection, a reduction in the diversity of 16 
microorganisms in a DFU was often observed due to expansion of one or two taxa, 17 
with recovery in diversity at resolution. Modelling of the predicted species interactions 18 
in a single DFU with high diversity indicated that networks of metabolic interactions 19 
may exist that contribute to the formation of stable communities. 20 
 21 
Conclusion: Longitudinal profiling is an essential tool for improving our understanding 22 
of the microbiology of chronic wounds, as community dynamics associated with 23 
clinical events can only be identified by examining changes over multiple time points. 24 
The development of complex communities, particularly involving Enterobacteriaceae 25 
and strict anaerobes, may be contributing to poor outcomes in DFUs and requires 26 
further investigation.  27 
Introduction 28 
It is generally acknowledged that diabetic foot ulcers (DFUs) present a considerable 29 
clinical and economic burden (1, 2). They have multiple and various overlapping 30 
causes, including peripheral artery disease (PAD) and different modalities of 31 
neuropathy. As intact skin provides a natural barrier, ulceration and exposure of 32 
nutrient-rich tissues to the surface predisposes to colonisation with a wide array of 33 
microbes. Clinically apparent infection with known pathogens, such as 34 
Staphylococcus aureus, is recognised as an important cause of deterioration of pre-35 
existing DFUs and delayed healing (3, 4) and best practice is to sample DFUs with 36 
clinical signs of infection to identify them (5). However, little is known of interactions 37 
which may occur within a diverse community of micro-organisms (and/or with the host) 38 
which could result in delayed healing, subclinical tissue damage or predisposition to 39 
clinical infection. 40 
 41 
Advances in high throughput next generation sequencing (NGS) has enabled the 42 
molecular characterisation of entire microbial communities from any particular site, 43 
termed the microbiome. Profiling of marker genes, such as the 16S ribosomal RNA 44 
gene, or sequencing all the genetic material present in a sample provides an overview 45 
of the microbiome - including microorganisms which may be difficult to culture or be 46 
present in very low numbers (6). These large datasets can be analysed with data-47 
mining techniques to uncover relationships between the presence of various groups 48 
of microorganisms and clinical variables. In a cross-sectional study of soft tissue 49 
samples from 40 people with DFUs, Dowd (7) described a broader spread of taxa than 50 
previously identified by culture based methods, while in a more recent study of 52 51 
surface swabs from non-infected plantar neuropathic DFUs, Gardner and colleagues 52 
(8) reported clustering of identified bacterial taxa into three broad groups, 53 
demonstrating significant associations between bacterial groups and DFU depth, area 54 
and overall quality of glycaemic control. Further insight was provided by a study of 100 55 
subjects with DFUs from whom repeated samples were obtained in a subpopulation 56 
(9). The authors described four different types of bacterial community based on the 57 
dominant population of identified bacteria and also studied the extent to which these 58 
populations changed. They suggested that more frequent change in community types 59 
was a feature of those that healed within 12 weeks of observation. 60 
 61 
A deeper understanding of polymicrobial interactions and impact on host tissues could 62 
inform risk stratification tools for DFUs and facilitate the design of targeted 63 
interventions aimed at altering the colonising microbiota such as phage therapy. In the 64 
setting of infection, this may also enable more selective use of antibiotics where 65 
clinically appropriate to reduce broad spectrum antibiotic exposure. Sequencing costs, 66 
technical limitations and analytical barriers are constraining immediate application of 67 
microbiome profiling to the management of DFUs. However, developments in 68 
sequencing technologies, particularly those with potential point of care applications 69 
such as Oxford nanopore sequencing, promise to minimise these limitations in the 70 
foreseeable future (10). 71 
 72 
The data presented here were collected as a sub-study of a clinical trial investigating 73 
the effectiveness of a simple off-loading device in patients with DFUs affecting the 74 
heel (11). Swab samples were taken at the time of recruitment and at fortnightly 75 
intervals up to a maximum of 24 weeks until DFU healing or withdrawal from the parent 76 
study. Associations were sought between clinical measures and the microbiota, both 77 
at baseline and over the course of the study. Data available from the parent study 78 
provided baseline details of the participants as well as clinical information relating to 79 
DFU status at each study visit. 80 
  81 
Methods 82 
Participants in the parent trial were people with diabetes complicated by DFUs on the 83 
heel and were randomised to management either with standard good care plus 84 
lightweight fiberglass heel casts or with standard good care alone, and were reviewed 85 
in a specialist clinical research service every two weeks. The results of this parent 86 
study have been reported in full elsewhere (11). The present study was approved by 87 
Derby Research Ethics Committee (IRAS ID 137934). Participating centres were 88 
selected from those that were recruiting well to the parent study and which agreed to 89 
undertake the additional sampling. All participating patients provided additional 90 
informed consent. Since no difference in any outcome measure was observed 91 
between the intervention and the usual care arms of the parent study, samples from 92 
patients in both groups were combined for the present analyses.   93 
 94 
Details of sampling and sample handling 95 
Samples were obtained using flock swabs and the Z technique after cleansing and 96 
sharp debridement of the wound surface. Samples were identified only by study centre 97 
and study number. Each swab tip was retained in the collection tube and submerged 98 
in a PBS-based buffer solution (MoBio Powersoil Collection Fluid, CARLSBAD, CA) 99 
to maintain constant pH. For transport, the samples were packed in a protective plastic 100 
casing with a cold pack, boxed and sealed in a prepaid envelope and posted first class 101 
within 24 hours to a central microbiology laboratory at Nottingham University Hospitals 102 
NHS Trust. Samples were subsequently stored at -80 °C until extraction. 103 
 104 
DNA extraction 105 
DNA was extracted from the whole sample using the MoBio Powersoil Kit (since 106 
renamed to DNeasy PowerSoil Kit) as per manufacturer’s guidelines with a pre 107 
extraction homogenisation step (4500 rpm, 45 sec x 3). DNA was stored at -80 °C to 108 
await subsequent analysis. Obtained DNA was quantified using the Quant-iT™ 109 
PicoGreen™ dsDNA Assay Kit (Invitrogen, Waltham, MA) and analysed, in duplicate, 110 
on the ABI7500 (Applied Biosystems, Ca, USA). 111 
 112 
16S rRNA gene amplification, library preparation and sequencing 113 
Amplicons were generated for the V4 region of the 16S ribosomal RNA gene using 114 
the above extracted DNA as a template. Previously validated primers were used to 115 
amplify a 359bp amplicon of the V4 hypervariable region of the prokaryotic 16S 116 
Ribosomal RNA gene 117 
(515F:TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTGCCAGCMGCCGCG118 
GTAA, 119 
806R:GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGACTACHVGGGTWT120 
CTAAT) (12). 237 out of 256 samples received were successfully amplified.  121 
PCR clean-up was performed using the AMPure XP beads (Beckman Coulter, IN, 122 
USA) before proceeding to index PCR, which attached barcodes to individual samples 123 
and Illumina sequencing adapters using the Nextera XT Index Kit, as per Illumina (CA, 124 
USA) guidelines. Negative controls were included to account for reagent 125 
contamination (13). After index PCR, clean-up was repeated as above and amplicons 126 
were individually quantified using the Agilent Bioanalyser (CA, USA), prior to 127 
normalisation and pooling. The barcoded amplicon pool was run on the Illumina MiSeq 128 
using 2x250bp chemistry. Raw .fastq files were output for subsequent bioinformatics 129 
analysis. The sequencing data are publicly available in the European Nucleotide 130 
Archive (ENA, acc.no. PRJEB28661). 131 
 132 
16S rRNA sequence pre-processing and taxonomic assignment 133 
DNA sequence data was pre-processed with the mare package (14) in R (Foundation 134 
for Statistical Computing, Vienna, Austria) as follows: Paired-end reads were merged 135 
with quality filtering and trimmed to a uniform length (290 bp). After chimera filtering 136 
and clustering with USEARCH (15), reads were assigned to taxonomic labels by 137 
alignment with the RDP database (16) using UTAX and a confidence level of 0.6. Taxa 138 
below this cut off were annotated as unclassified at that taxonomic level and assigned 139 
to the next highest available level. Unique reads occurring at a frequency of less than 140 
1:100,000 were excluded to avoid OTU inflation. Two halophilic genera Halomonas 141 
and Shewanella were identified from negative controls as possible contaminants and 142 
excluded from the analysis. 143 
 144 
Oxford nanopore library preparation and sequencing 145 
Swab DNA extracts were treated with a NEBNext Microbiome DNA Enrichment Kit 146 
(New England Biolabs) to enrich microbial DNA prior to sequencing (17). Library 147 
preparation was performed with a Rapid Low Input by PCR Barcoding Kit (SQK-148 
RLB001, Oxford Nanopore Technologies) and libraries sequenced on the MinION 149 
platform (Oxford Nanopore Technologies). Base calling was performed with Albacore 150 
Sequencing Pipeline Software (version 2.1.2, Oxford Nanopore Technologies) with 151 
raw .fastq files output for subsequent analysis. 152 
 153 
Direct sample sequencing analysis 154 
MinION reads were screened against the human genome reference hg19 (GenBank 155 
assembly GCA_000001405.1) using Minimap2 (18) to remove host DNA 156 
contamination. The resulting non-human sequences were annotated with Centrifuge 157 
1.0.3 (19) using the default database for bacteria and archaea. A minimum hit length 158 
of 50 and hit length covering at least 5 % of the read were used to filter the resulting 159 
annotations. For detection of antimicrobial resistance genes, all of the non-human 160 
reads for the sample were assembled using Canu 1.7 (20). The resulting contiguous 161 
sequences were assigned a taxonomic identification by Centrifuge and then input to 162 
ResFinder 3.0 (21) searching for acquired antimicrobial genes with a 95 % identity 163 
threshold. 164 
 165 
Statistical and network analysis 166 
Alpha diversity (Inverse Simpson Index, variation within any one sample) and beta 167 
diversity (Bray-Curtis Dissimilarity (BCD), variation between samples) were calculated 168 
using the vegan package (22) in R (Foundation for Statistical Computing, Vienna), with 169 
Principal Coordinates Analysis of BCD and PERMANOVA used for analysis of 170 
multivariate microbiota count data. Associations between diversity and clinical 171 
categories were tested for using unpaired t-test or ANOVA after assessing for 172 
normality with the Shapiro-Wilk method. 173 
To enable analysis of changes occurring within individual DFUs over time, samples 174 
were assigned to clusters based on taxonomic profile. Sample clusters were created 175 
with the default k-means clustering function in R using relative abundances of taxa at 176 
family level with 150 maximum iterations and 10 simulated starts. After examining the 177 
relationship between variance explained and cluster number, six clusters were chosen 178 
to best represent the data (Supplementary Fig. 1). 179 
Once samples had been assigned to one of the six clusters, a Markov Model was 180 
constructed by counting all cluster transitions over consecutive visits and the counts 181 
converted to proportional probabilities by the dividing of total transitions from that 182 
cluster. If swab data were unavailable for the subsequent visit, the next available visit 183 
was used as the destination cluster. The final cluster for each subject was then used 184 
to calculate the probability of transition from each cluster to a healed or unhealed state 185 
at study end. Differences in transition probabilities between healed and unhealed 186 
DFUs were calculated using a log likelihood ratio test. 187 
A metabolic complementarity network was created from the MinION data by using the 188 
NetSeed pairwise metabolic complementarity index (MCI) previously calculated by 189 
Levy and Borenstein for 154 species found in the human microbiome (23, 24). Briefly, 190 
NetSeed requires as input a metabolic network for each species, based on a list of 191 
KEGG reactions per genome available from the Integrated Microbial Genomes project 192 
(IMG, http://img.jgi.doe.gov) and generated as described previously (25). The seed 193 
set of the network identified by NetSeed represents exogenously acquired compounds 194 
which appear as reaction substrates but not products. The MCI is a pairwise 195 
comparison of the proportion of the seed set from one species which are products but 196 
not seeds in a partner species network, thereby representing complementary by-197 
products. The most closely related species for which an MCI score was available was 198 
identified for each of the most abundant taxa in the DFU.  These scores were used to 199 
create a network with each species represented by a node, and each pairwise MCI 200 
score with a value greater than 0.5 represented by a directed edge towards the 201 
species from which benefit is predicted to be derived. 202 
  203 
Results 204 
DFU characteristics and microbiota composition 205 
Two hundred and thirty-seven samples were analysed from the index DFU from 28 206 
individuals, of which eight healed during the study period (Supplementary Table 1). 207 
The median (IQR) age of the participants was 70.5 (60-77) years. Twenty (71%) were 208 
male and 24 (86%) had Type 2 diabetes. The median (IQR) DFU area at 209 
randomisation was 161.5 (69-593) mm2.  210 
Characterisation of the microbiota of each sample by 16S rRNA sequencing identified 211 
63 distinct genera from 37 families, of which the 10 most abundant families accounted 212 
for 89.6 % of the overall composition (Supplementary Table 2). The most abundant 213 
taxonomic groups were Corynebacterium (22.7 %), Staphylococcus (15.2 %), 214 
unclassified Enterobacteriaceae (10.6 %), Anaerococcus (6.4 %), Pseudomonas (6.1 215 
%) and Streptococcus (4.6 %). The majority of the variation between the samples 216 
could be explained by subject, indicating that the microbiome of any one DFU tended 217 
to be distinct from any other (PERMANOVA, 63.7 % variance explained, p < 0.001). 218 
There was no correlation between baseline DFU area or NPUAP depth score and 219 
microbial diversity (alpha diversity, Inverse Simpson Index, ISI). 220 
Clustering analysis indicated that samples could be separated into six distinct groups 221 
based on broad compositional differences, with one or two highly abundant taxa 222 
characterising each cluster (Supplementary Fig. 2). Clusters were assigned a letter 223 
based on dominant taxa; cluster 1 (n = 20, Pseudomonaceae 58.1 % – P), cluster 3 224 
(n = 49, Corynebacteriaceae 68.3 % – C), cluster 4 (n = 17, Micrococcaceae 87.2 % 225 
– M) and cluster 6 (n = 34, Staphylococcaceae 74.6 % - S) were relatively 226 
homogenous while cluster 2 (n = 61, Enterobacteriaceae 33.4 % – E) and cluster 5 (n 227 
= 56, Clostridiales Incertae Sedis XI 38.2 % and other anaerobes ~ 20 % - A) exhibited 228 
greater taxonomic diversity. 229 
 230 
Variations in microbial community dynamics between healing and non-healing 231 
DFUs 232 
We sought to investigate whether the microbiota of non-healing DFUs were different 233 
to healing DFUs in both overall composition and changes over time.   234 
Of all the 51 samples taken from the 8 DFUs which healed, the majority of samples 235 
fell into either the C (17/51, 33.3 %) or S (11/51, 21.6 %) clusters while of the 186 236 
samples taken from 28 unhealed DFUs, the E (52/186, 28.0 %) and A (48/186, 25.8 237 
%) clusters were most frequently represented. Mean baseline alpha diversity in 238 
healing DFUs was 2.3 (+/- 0.9) compared to 2.9 (+/- 1.5) for those that did not heal, 239 
but this difference was not statistically significant (p = 0.19).   240 
For each DFU, the transition in the microbiota between clusters over subsequent visits 241 
was used to develop a Markov model (Supplementary Fig. 3 and Supplementary Table 242 
3). The microbiota of individual DFUs tended to remain within the same cluster over 243 
subsequent visits with probabilities ranging from 53 % of samples in the S cluster to 244 
71 % in the M cluster. No transitions were observed between the S and P cluster while 245 
transitions frequently occurred from the A to E cluster (Probability = 20 %) although 246 
less frequently from E to A (8 %). 247 
Specific features of healing and non-healing DFUs were identified from the changes 248 
in the microbiota profiles over time. Non-healing DFUs with profiles of either E or A 249 
were less likely to transition away from these to other clusters than healing DFUs 250 
(probably per visit; non-healing 21 % vs healing 59 %, log likelihood ratio 9.56, p = 251 
0.008). In DFUs which healed, high rates of transition were observed from E towards 252 
several clusters, particularly S (33 %) and C (22 %) so that in the final visit before 253 
healing, 75 % healed DFUs had a microbiota profile of either S (3/8) or C (3/8) with 254 
only 1 each in the E and P clusters and none in either M or A.  255 
Individual profiles from DFUs which were consistent with these overall trends are 256 
illustrated in Fig. 1.  In Fig. 1(a), the DFU was persistently colonised by a high 257 
proportion of Corynebacterium and Staphylococcus with two episodes of infection 258 
treated with co-amoxiclav before finally healing. Fig. 1(b) is an example of one of two 259 
DFUs where 3 consecutive samples fell into the E or A clusters with high proportions 260 
of anaerobes and Enterobacteriaceae observed, accompanied by visible slough, 261 
before emergence of Corynebacterium and Staphylococcus immediately prior to 262 
healing. In the profile displayed in Fig. 1(c), Enterobacteriaceae and anaerobes are 263 
highly abundant during several visits before gradual replacement with Pseudomonas 264 
pre-healing. Fig. 1(d) is an example of a non-healing DFU where various anaerobes 265 
and Enterobacteriaceae are present throughout. 266 
 267 
Changes in the microbiota associated with infection and antibiotic therapy 268 
Forty-six percent (13/28) of subjects had at least one episode of clinical infection, with 269 
a total of 20 discrete episodes of infection identified covering 44 visits.  270 
Infection and antibiotic use often co-occurred such that their relative associations with 271 
sample diversity could not be readily distinguished. Overall, samples from infected 272 
DFUs exhibited lower microbial diversity than those from uninfected DFU (infected 2.2 273 
+/- 0.9 vs uninfected 3.1 +/- 1.5, p = 1x10-6), while diversity also appeared to be lower 274 
for visits where subjects were receiving antibiotic therapy (antibiotics 2.4 +/- 1.2 vs no 275 
antibiotics 3.1 +/- 1.5, p = 0.001). Analysing the contribution of both variables indicated 276 
that infection was likely to be a greater contributor to the fall in diversity (ANOVA, F = 277 
14.0, p < 0.001) than antibiotic exposure (F = 2.1, p = 0.15). 278 
To further investigate the changes in microbial diversity associated with individual 279 
episodes of infection, samples from visits occurring either immediately preceding, 280 
during and following an episode of clinical infection were aligned and the microbial 281 
diversity plotted. This demonstrated a reduction in microbial diversity at the onset of 282 
infection with a corresponding recovery in diversity beginning from the final visit where 283 
infection was noted clinically (Fig. 2). 284 
Across all samples taken from infected DFUs, cluster E (24/44, 54.5 %) and C (11/44, 285 
25.0 %) were the most prevalent overall, and this was the same for the first visit of 286 
each episode of infection (cluster E: 10/20, 50.0 %; cluster C: 4/20, 20.0 %). Despite 287 
the recognised importance of Staphylococcus aureus as a pathogen in this context, 288 
only 1 DFU had a high proportion of Staphylococcus at infection onset, falling into the 289 
S cluster. There were 3 and 2 episodes of infection beginning with profiles in the P 290 
and A clusters, respectively. 291 
Further individual profiles demonstrating temporal changes in the microbiota 292 
associated with episodes of clinical infection are shown in Fig. 3. In the DFU profile 293 
shown in Fig. 3(a), colonisation at baseline with a mixture of Kocuria and other 294 
Micrococcaceae was observed with an initial alpha diversity index of 1.96. At visit 7, 295 
this fell to 1.15 following the emergence and expansion of staphylococci within the 296 
DFU, associated with an episode of clinical infection. After commencement of anti-297 
staphylococcal antibiotic therapy (flucloxacillin), the profile reverted to the taxa which 298 
were originally dominant. 299 
Several episodes of infection occurred in the DFU shown in Fig. 3(b) which had a high 300 
baseline diversity index of 4.79, falling to 1.37 at visit 5 due to an expansion of 301 
Streptococci, with associated clinical infection from visits 3 to 6. Recovery of microbial 302 
diversity to 4.6 at visit 7 with emergence of Enterobacteriaceae and later 303 
Pseudomonas were also observed. 304 
In Fig. 3(c), a DFU colonised with a high proportion of anaerobes over successive 305 
visits from 4 to 6 with high diversity (visit 6: 7.81) underwent a dramatic reduction in 306 
diversity during an episode of clinical infection at visit 10 (2.58) accompanied by an 307 
expansion of Anaerococcus and Peptonophilus.  After a course of co-amoxiclav, the 308 
anaerobes were no longer abundant at visit 11, having been replaced by 309 
Enterobacteriaceae. 310 
The profile shown in Fig. 3(d) shows a DFU colonised by Enterobacteriaceae, 311 
Pseudomonas and Corynebacterium. Onset of infection at visit 8 and empirical 312 
treatment with doxycycline was followed later by expansion of Streptococci from visit 313 
8 to 9. After a second course of ciprofloxacin and metronidazole, diversity was 314 
markedly reduced from 3.8 at visit 9 to 1.1 at visit 11 as Corynebacterium replaced the 315 
other taxa to become the dominant organism in the DFU. 316 
In addition to the cases described above, abrupt changes were also noted in certain 317 
DFUs without any obvious cause such as antibiotic exposure or clinical infection. In 318 
other cases the clinical diagnosis of infection was documented but there were no 319 
obvious associated changes in the microbiota (Supplementary Fig. 4). 320 
 321 
Direct sample sequencing identifies individual species and resistance genes 322 
Short-read sequencing of 16S rRNA amplicons enables high throughput community 323 
profiling but is limited by taxonomic resolution and does not provide any additional 324 
information about the genetic capability of a community. To complement the 16S 325 
profiles, we conducted longer read sequencing using the Oxford Nanopore MinION on 326 
the swab DNA extracts for the profile shown in Fig. 3(b). This profile was chosen as it 327 
was one of the most diverse profiles containing a mixture of taxa including 328 
Streptococci, Enterobacteriaceae, Pseudomonas and several strict anaerobes. 329 
Seven samples were sequenced from alternate visits (1, 3, 5, 7, 9, 11, and 13). Despite 330 
a microbiome enrichment step, only 3 samples yielded > 1000 reads once host DNA 331 
sequences had been discarded (V3 16900, V5 2353, V9 2127).  After performing 332 
sequence annotation with the taxonomic classifier, Centrifuge, (19) and applying strict 333 
cut-offs to the output to optimise the accuracy of taxonomic identification, only a small 334 
proportion of reads were eventually assigned to a bacterial species (V3 1548, V5 426, 335 
V9 172). Taxa identified from V3 compared well to the 16S profile (Fig. 4a). While read 336 
numbers were low for V5 and V9, the species identified were also consistent with the 337 
16S results, including Streptococcus anginosus (V5, V9), Escherichia coli (V5, V9), 338 
Enterococcus faecalis (V5), Staphylococcus aureus (V5), Bacteroides fragilis (V9) and 339 
Porphyromonas asaccharolytica (V9).  340 
Analysing the V3 sample for the presence of antimicrobial resistance genes using the 341 
ResFinder tool (21) identified tet, erm and cfx genes. Assembling the sequences from 342 
this sample and performing taxonomic annotation on the resulting assembly enabled 343 
the matching of tetM, ermA and ermB to Streptococcus anginosus and cxfA and tetQ 344 
to Prevotella intermedia based on the presence of these genes in continuous DNA 345 
sequence with a high quality taxonomic assignment. 346 
Finally, using the more detailed taxonomic profile created from this DFU, we compiled 347 
a network of potential inter-species interactions based on a metabolic complementarity 348 
index (MCI) previously calculated by Levy et al. (23) using the NetSeed algorithm (24) 349 
(Fig. 4b). Higher scores on the MCI indicate a species is predicted to derive metabolic 350 
benefit from the metabolic by-products of the partner species. The strict anaerobes, 351 
particularly Porphyromonas asaccharolytica, are predicted to derive benefit from a 352 
number of other species, particularly E. coli and P. aeruginosa, whereas E. coli is 353 
predicted to confer benefit on all the strict anaerobes, E. faecalis and S. anginosus, 354 
but may not itself derive much metabolic benefit from the presence of these species. 355 
  356 
Discussion 357 
We have characterised the variation in the microbiota of 28 DFUs using a high-358 
resolution longitudinal sampling approach over a 6 month period, or until DFU healing. 359 
Successive longitudinal sampling is particularly valuable in this context as we were 360 
able to observe changes in the DFU microbiota occurring over short time frames and 361 
in conjunction with clinical events such as impending healing, infection or antibiotic 362 
administration. 363 
 364 
The most abundant taxa identified in this study were similar to those found in other 365 
molecular studies of DFUs, although the proportions vary between studies (8, 9, 26). 366 
We observed a dominance of Gram positive organisms including Corynebacteria (22.7 367 
%), Staphylococci (15.2 %) and anaerobic members of the families Clostridiales 368 
Incertae Sedis X (total 13.4 %, including Anaerococcus, Finegoldia and Peptinophilus) 369 
and Micrococcaceae (7.9 %), with a lower abundance of Gram negative organisms; 370 
predominantly the family Enterobacteriaceae (11.5 %) and Pseudomonas (6.1 %). By 371 
comparison, Wolcott et al. (26) identified Staphylococcus aureus (15.0 %) and 372 
Staphylococcus epidermidis (10.7 %) as the most abundant species in 910 DFUs of 373 
all types using 16S amplicon pyrosequencing with high proportions of Pseudomonas 374 
aeruginosa, Corynebacterium spp., Enterococcus spp., Finegoldia magna and 375 
Anaerococcus vaginalis also present. The proportions observed here are likely to 376 
reflect the patient group and DFU type selected for the parent study. 377 
 378 
There are likely to be a large number of factors which are responsible for shaping the 379 
microbiota of an individual DFU. These will include bacteria already present on intact 380 
skin and elsewhere in the body prior to ulceration, as well as the microenvironment 381 
influenced by oxygen tension, glycaemic control, chronicity of the wound and historical 382 
antibiotic exposure (8, 27, 28). This would explain why samples from any one DFU 383 
tended to be similar to each other, but often varied greatly in composition to other 384 
DFUs. By contrast, the gut microbiota are heavily influenced by dietary intake and 385 
tends to be composed of a core group of taxa in individuals who share a similar diet 386 
(29). 387 
 388 
To overcome the challenge of comparing a heterogeneous group of samples from a 389 
limited DFU population, we used a clustering approach similar to that employed in 390 
other molecular studies of DFUs (8, 9). Clustering at family level facilitated the 391 
grouping of organisms with overlapping genomic content and growth requirements 392 
such as the variety of closely related anaerobes within the Clostridiales Incertae Sedis 393 
X. The resulting six clusters were relatively homogeneous, consistent with the most 394 
abundant taxa identified and captured a significant proportion of the overall variation 395 
in the data. Repeat sampling from individual DFUs yielded profiles from the same 396 
cluster on at least 50 % of visits, consistent with the observation that individual DFUs 397 
tended to have unique profiles and retained the same combinations of taxa over time. 398 
 399 
Impaired healing of DFUs is influenced by a variety of factors notably ischaemia and 400 
neuropathy, but also subtle cellular deficits, particularly impaired leucocyte function 401 
and alterations in the normal inflammatory response (4, 30-32). There is a growing 402 
body of evidence that the composition of the chronic wound microbiome may also 403 
have an impact, but the possible mechanisms for this are not well understood. In a 404 
murine wound model comparing wild-type to diabetic mice, Grice et al. (33) observed 405 
delayed healing in diabetic mice with differences in gene expression associated with 406 
the immune response, and increased abundance of Staphylococcus, Aerococcus and 407 
taxa within the Enterobacteriaceae and Porphyromonadaceae. In a compelling study, 408 
Wolcott et al. (34) sampled the microbiota from 43 chronic wounds and observed that 409 
83% of these interfered with healing when transplanted into a murine chronic wound 410 
model. 411 
 412 
In this study, we observed a tendency towards persistent colonisation with a 413 
heterogeneous population of bacteria including Enterobacteriaceae and several 414 
groups of Gram positive and Gram negative anaerobes in DFUs which failed to heal. 415 
DFUs which healed tended to be colonised with high proportions of Gram positive 416 
aerobes, particularly staphylococci and corynebacteria, prior to healing. An obvious 417 
explanation for these findings is that the microbiota are simply determined by the DFU 418 
environment; chronic non-healing wounds promoting the growth of organisms 419 
preferring moist sites while DFUs which have almost healed supporting organisms 420 
commonly found on intact skin. The alternative possibility that must also be considered 421 
however, particularly in light of other studies in this area, is that colonisation with 422 
certain combinations of microbes may itself be a contributor to delayed healing. In a 423 
murine chronic wound model, Dalton et al. (35) found that a polymicrobial mixture of 424 
Gram positive and Gram negative aerobes and anaerobes was associated with 425 
delayed healing compared to wounds colonised with a single organism. Loesche et al. 426 
(9) also studied longitudinal profiles of the microbiota in DFUs and while they did not 427 
identify specific groups of bacteria associated with poor healing, they also observed 428 
that non-healing DFUs tended to have a stable microbiome with less variation over 429 
time than healing DFUs. 430 
 431 
In addition to environmental factors, competition for nutrients and metabolic synergy 432 
between microbes is another key determinant of community composition (36). 433 
Analysing the predicted metabolic overlap between species co-occurring in one DFU 434 
in this study indicated that strict anaerobes are the likely principal beneficiaries of such 435 
metabolic overlap. Anaerobes such as Porphyromonas benefit from poor tissue 436 
oxygenation in diabetes and possibly also increased levels of metabolic substrates 437 
such as alpha-ketoglutarate (37, 38). They may also benefit from micro-anaerobic 438 
climates created by other bacteria lowering redox potential, forming surface layers 439 
including biofilm and exchange of metabolic by-products. Studies of the microbiome 440 
in periodontal disease have already demonstrated the importance of groups of 441 
organisms, including anaerobes, working together to impair the host response, 442 
degrade connective tissue and promote chronic inflammatory states (39). 443 
 444 
Diversity of individual samples tended to be lower during episodes of clinical infection 445 
and on antibiotic therapy. In some instances this appeared to indicate the proliferation 446 
of potentially pathogenic organisms which may have resulted in the clinical symptoms 447 
observed. Alternatively, it could be that inflamed wounds represent a changed local 448 
environment in which certain bacteria are able to flourish while others are not. Certain 449 
bacteria, such as E. coli, are able to use inflammatory mediators, for example nitric 450 
oxide, as metabolic substrates potentially giving them a survival advantage in pro-451 
inflammatory environments (40). Interactions between microbes may result in the 452 
promotion or suppression of certain species with virulence potential. Another possible 453 
mechanism by which community dynamics may influence the onset of infection is 454 
through modulation of virulence potential by inter-species interaction. Ramsey et al. 455 
observed that Corynebacterium striatum was capable of interfering with quorum 456 
sensing in Staphylococcus aureus with the effect of suppressing virulence factor 457 
production (41). While high proportions of staphylococci were only observed in 1 in 20 458 
cases of developing infection, it is possible that proliferation of other species may have 459 
altered virulence factor expression by less abundant pathogens such as 460 
Staphylococcus aureus, resulting in tissue damage, inflammation and clinically 461 
apparent infection. 462 
 463 
16S rRNA amplicon sequencing enables the identification of organisms that are 464 
difficult to isolate with conventional culture, while giving an estimate of the proportion 465 
of bacterial taxa present in the sample. Despite potential high throughput and low cost, 466 
the principal limitation of short-read sequencing is that taxa cannot be reliably 467 
identified to the lowest taxonomic levels, particularly species but also genus in some 468 
cases. As higher level taxonomic groupings, such as the family Enterobacteriaceae, 469 
can contain a wide range of organisms with greatly differing virulence potential, this is 470 
a significant drawback. Nonetheless, this form of molecular survey is capable of 471 
yielding important insights into the bacterial community dynamics of a DFU and how 472 
this relates to clinical events, more so than phenotypic testing. Microbiota profiles were 473 
often similar over multiple visits, both in the most abundant taxa identified and their 474 
relative proportions. This suggests that the approaches used for sampling, extraction, 475 
amplification and sequencing were likely to be relatively consistent between samples. 476 
 477 
To complement the 16S analysis, we also analysed swab DNA extracts directly with 478 
Oxford nanopore sequencing technology, which is the first time to our knowledge that 479 
this has been applied to diabetic wounds. Sequencing the total pool of the DNA in a 480 
sample enabled greater taxonomic resolution and identification of antibiotic resistance 481 
genes. The amount of information which could be determined from a sample appeared 482 
to be directly proportional to the ratio of host to bacterial DNA recovered, as any host 483 
DNA sequenced reduced bacterial read depth. The high proportion of host DNA in 484 
many of the samples limited a comprehensive characterisation of the microbiota. 485 
Technical challenges to be overcome include the optimisation of sample extraction 486 
methods and reduction in the proportion of host DNA, however the capacity for rapid 487 
sequencing is an appealing prospect for diagnostic utility. 488 
 489 
Given the longitudinal study design and need for fortnightly sampling, ulcer base 490 
swabs were chosen over tissue sampling. Aside from drawbacks of the sequencing 491 
technologies used, this is another potential study limitation as surface swabs may not 492 
detect the invasion and proliferation of bacteria in tissue layers during infection. In a 493 
cross sectional study of wound swab versus tissue sampling, Nelson et al. detected a 494 
higher proportion of tissue samples containing at least one recognised pathogen (86.1 495 
%) vs. swabs (70.1 %) with fewer less pathogenic organisms in tissue (42). Host DNA 496 
proportions are likely to be even higher in tissue samples than from swabs, however 497 
longitudinal microbiota characterisation from tissue samples could potentially give 498 
clearer insight into the dynamics of infection if these considerable practical and 499 
technical difficulties can be overcome. 500 
 501 
This study has yielded important information of the microbiology of difficult to heal 502 
DFUs of the heel, including differences in microbial diversity and changes over time in 503 
infected, healing and non-healing DFUs. While heel ulcers are a subtype of DFUs, 504 
they represent a wide range of DFU types from the small and superficial to the deep 505 
and anaerobic. We anticipate that building on this and similar studies by analysing a 506 
greater number and employing a wide range of sequencing strategies, including full 507 
metagenomics and transcriptional analysis, will add to our understanding of the 508 
mechanisms underlying non-healing DFUs with implications for future basic and 509 
translational research studies in this field. 510 
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  674 
Figure 1. Examples of DFU profiles where healing occurred during the study. 675 
(a) Healing DFU profile largely dominated by Corynebacterium and Staphylococcus. 676 
(b) Healing DFU with transition from anaerobes and Enterobacteriaceae to 677 
Corynebacterium and Staphylococcus. (c) Healing DFU with disappearance of 678 
Enterobacteriaceae and anaerobes in the visits preceding healing. (d) Example of a 679 
non-healing DFU persistently colonised by mixed anaerobes and Enterobacteriaceae. 680 
Infection, antibiotic exposure or high microbial diversity is indicated by red on the 681 
colour map, while absence of infection, antibiotic exposure or low microbial diversity 682 
is indicated by green. DFU cluster designations; P = Pseudomonaceae, E = 683 
Enterobacteriaceae, C = Corynebacteriaceae, S = Staphylococcaceae, A = 684 
Anaerobes, M = Micrococcaceae, N = Non-healing at study end, H = Healed. 685 
  686 
 687 
  688 
Figure 2. Changes in diversity associated with onset and resolution of infection. 689 
Alpha diversity (Inverse Simpson Index) plotted for DFU samples taken before, during 690 
and after all documented episodes of infection. (a) Fall in alpha diversity associated 691 
with onset of infection where visit 0 is the first visit where a new infection is observed 692 
clinically, visit -2 and -1 the two preceding visits with no infection and visit 1 and 2 any 693 
subsequent visits with persistent infection. (b) Recovery in alpha diversity associated 694 
with resolution of infection where visit 0 is the final visit where infection is observed 695 
clinically, visit -2 and -1 any preceding visits with infection and visit 1 and 2 any 696 
subsequent visits where infection had resolved. The trend line indicates changing 697 
diversity calculated by local polynomial regression fitting with the shaded area 698 
indicating the 95% confidence intervals. 699 
  700 
  701 
Figure 3. Examples of DFU profiles where clinical infection occurred. 702 
 (a) Expansion of Staphylococcus associated with clinical infection at visit 7 and 703 
subsequent decline following treatment with flucloxacillin at visit 8. (b) Episodes of 704 
clinical infection observed in a profile dominated by Streptococcus with later 705 
emergence of Pseudomonas and Enterobacteriaceae. (c) High diversity seen at visit 706 
6 markedly reduced at visit 10, with other anaerobes replaced by Anaerococci and 707 
Peptonophilus.  An episode of clinical infection was treated with co-amoxiclav with 708 
subsequent expansion of Enterobacteriaceae. (d) Infection associated with 709 
emergence and expansion of Streptococcus followed by treatment with ciprofloxacin 710 
after visit 9 and accompanying elimination of Streptococcus and Enterobacteriaceae. 711 
Infection, antibiotic exposure or high microbial diversity is indicated by red on the 712 
colour map, while absence of infection, antibiotic exposure or low microbial diversity 713 
is indicated by green. DFU cluster designations; P = Pseudomonaceae, E = 714 
Enterobacteriaceae, C = Corynebacteriaceae, S = Staphylococcaceae, A = 715 
Anaerobes, M = Micrococcaceae, N = Non-healing at study end, H = Healed. 716 
  717 
 718 
  719 
Figure 4. Direct sample sequencing enables identification of species and 720 
resistance genes 721 
 (a) Detailed analysis of the DFU profile shown in Fig. 3(b), comparing taxonomic 722 
identifications based on Illumina 16S rRNA and Oxford Nanopore MinION direct 723 
sample sequencing taken during an episode of clinical infection at visit 3. 724 
(b) Potential network of inter-species interaction for representative species based on 725 
this DFU profile, created using the Metabolic Complementary Index (23). Edges are 726 
shown for all scores greater than 0.5. Higher scores are reflected by greater edge 727 
thickness with arrows directed towards the partner species from which metabolic 728 
benefit is predicted to derive. 729 
  730 
Supplementary Table 1. Patient demographics and DFU details. 731 
 732 
Baseline patient demographics and DFU details for all 28 study participants. DFUs 733 
which healed or developed clinical infection during the study are indicated by ‘Yes’ or 734 
‘No’ in the Healed and Infection columns respectively. NPUAP = National Pressure 735 
Ulcer Advisory Panel depth grade. ISI = Inverse Simpson Index.  736 
Age Sex DFU 
depth 
(NPUAP) 
DFU size 
(mm²) 
Healed Infection Alpha 
diversity 
(ISI) 
Profile figure 
reference 
37 M II 70 Yes No 3.25 
 
63 M II 261 No No 2.05 
 
62 M III 618 No Yes 3.53 
 
84 M III 30 No Yes 5.25 
 
60 M III 1203 No Yes 5.73 Fig. 3(c) 
58 M III 50 No No 1.60 
 
77 F III 251 No No 5.22 
 
74 M III 103 No No 1.44 
 
45 M III 1713 No Yes 3.21 Supp. Fig. 4(c) 
68 M III 700 Yes No 2.33 Fig. 1(b) 
73 M II 891 No No 3.03 Fig. 1(d) 
71 M II 19 No No 3.15 Supp. Fig. 4(a) 
42 F II 109 Yes No 1.04 Fig. 1(c) 
81 F II 930 No Yes 1.11 Fig. 3(d) 
71 M III 344 No Yes 2.93 
 
61 M III 146 Yes Yes 3.30 Fig. 1(a) 
79 F III 287 No Yes 1.10 Supp. Fig. 4(d) 
81 F III 114 No Yes 1.96 Fig. 3(a) 
56 M II 107 No No 3.28 
 
88 M II 61 No No 3.22 
 
62 M III 25 Yes Yes 2.85 
 
70 M III 37 No Yes 3.03 
 
56 M III 33 No No 1.05 
 
76 F III 177 No No 1.09 Supp. Fig. 4(b) 
73 M IV 990 Yes No 1.74 
 
79 M III 69 Yes Yes 1.10 
 
50 F III 593 No Yes 4.79 Fig. 3(b), Fig. 4 
85 F II 184 Yes No 2.49 
 
Supplementary Table 2. Highly abundant taxa. 737 
 738 
The 10 most abundant taxa at family level are shown according to mean proportional 739 
abundance across all 237 DFU samples. Dominant genera are indicated for each 740 
family.741 
Family Abundance 
(%) 
Dominant genera 
Corynebacteriaceae 22.7 Corynebacterium (22.7 %) 
Staphylococcaceae 15.3 Staphylococcus (15.2 %) 
Clostridiales Incertae 
Sedis X 
13.4 Anaerococcus (6.4 %), Finegoldia (2.4 %), 
Helcococcus (1.8 %) 
Enterobacteriaceae 11.5 Unclassified (10.6 %), Morganella (0.5 %) 
Micrococcaceae 7.9 Kocuria (3.9 %), Unclassified (3.1 %), 
Arthrobacter (0.8 %) 
Pseudomonadaceae 6.1 Pseudomonas (6.1 %) 
Streptococcaceae 4.6 Streptococcus (4.6 %) 
Moraxellaceae 3.2 Acinetobacter (3.0 %) 
Prevotellaceae 2.8 Prevotella (2.8 %) 
Actinomycetaceae 2.1 Arcanobacterium (0.9 %), Actinobaculum (0.8 %) 
Supplementary Table 3. DFU cluster transition probabilities 742 
All DFUs 
From To Count 
 
P E C M A S N H 
 
P 0.65 0.15 0.05 0.00 0.05 0.00 0.05 0.05 20 
E 0.05 0.56 0.11 0.00 0.08 0.08 0.10 0.02 61 
C 0.02 0.06 0.67 0.00 0.06 0.02 0.10 0.06 49 
M 0.00 0.00 0.00 0.71 0.00 0.18 0.12 0.00 17 
A 0.02 0.20 0.04 0.00 0.64 0.04 0.07 0.00 56 
S 0.00 0.09 0.06 0.09 0.09 0.53 0.06 0.09 34 
 
Healed DFUs 
From To Count 
 P E C M A S N H  
P 0.50 0.17 0.00 0.00 0.17 0.00 0.00 0.17 6 
E 0.11 0.11 0.22 0.00 0.11 0.33 0.00 0.11 9 
C 0.00 0.00 0.65 0.00 0.12 0.06 0.00 0.18 17 
M 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0 
A 0.13 0.25 0.25 0.00 0.38 0.00 0.00 0.00 8 
S 0.00 0.09 0.09 0.00 0.00 0.55 0.00 0.27 11 
 
Unhealed DFUs 
From To Count  
P E C M A S N H 
 
P 0.71 0.14 0.07 0.00 0.00 0.00 0.07 0.00 14 
E 0.04 0.63 0.10 0.00 0.08 0.04 0.12 0.00 52 
C 0.03 0.09 0.69 0.00 0.03 0.00 0.16 0.00 32 
M 0.00 0.00 0.00 0.71 0.00 0.18 0.12 0.00 17 
A 0.00 0.19 0.00 0.00 0.69 0.04 0.08 0.00 48 
S 0.00 0.09 0.04 0.13 0.13 0.52 0.09 0.00 23  
 743 
Transition probabilities for movement between DFU clusters over subsequent visits 744 
for all DFUs (n = 28) and also separated by DFUs which went on to heal (n = 8) and 745 
those that did not (n = 20). Probability of movement between clusters is shown from 0 746 
(no probability) to 1 (guaranteed probability) with the number of samples falling into 747 
each of the 6 clusters shown in the count column. Self-transitions are italicised. P = 748 
Pseudomonaceae, E = Enterobacteriaceae, C = Corynebacteriaceae, M = 749 
Micrococcaceae, A = Anaerobes, S = Staphylococcaceae, N = non-healing state 750 
(study end), H = healed DFU.  751 
 752 
 753 
Supplementary Figure 1. Cluster variance explained by increasing number of 754 
clusters. Plot of variance explained by increasing the numbers of clusters used, 755 
showing the trade-off between clustering complexity and fit to the data. The change in 756 
trajectory in moving from 5 to 6 clusters compared to 6 to 7 clusters is shown with 757 
dashed lines indicating the diminishing returns associated with using a higher number 758 
of clusters. 759 
  760 
 761 
 762 
Supplementary Figure 2. Clustering of DFU samples by major taxonomic 763 
groups.  764 
DFU samples were clustered at family level by k-means clustering and assigned to 765 
one of 6 clusters, labelled according to most abundant taxa. DFU cluster designations; 766 
P = Pseudomonaceae, E = Enterobacteriaceae, C = Corynebacteriaceae, S = 767 
Staphylococcaceae, A = Anaerobes, M = Micrococcaceae. (a) Mean proportional 768 
abundance of the taxa in each cluster. The E and A clusters contained were the most 769 
heterogeneous, representing a more diverse combination of different taxa. (b) 770 
Principal coordinates analysis showing the distribution of samples at genus level, with 771 
samples coloured by cluster. Samples in the low diversity C, M and S clusters were 772 
well discriminated by the first two principal components while samples from clusters 773 
E, A and P tended to overlap and were more widely spread. DFU clusters accounted 774 
for a significant proportion of the overall variance when analysed with PERMANOVA 775 
(7 % variance explained, p = 0.001). 776 
  777 
 778 
 779 
Supplementary Figure 3. Transition between DFU clusters during the study.  780 
A Markov model demonstrating the transition between DFU clusters between visits 781 
until either healing (H) or non-healing at study end (N) for 237 samples from 28 782 
subjects combining both healing (n=8) and non-healing (n=20) DFUs. The size of the 783 
nodes indicates the number of samples in each state while the edge and arrow weights 784 
represent the probability of transition between states. Transition probabilities within 785 
nodes or to the endpoints (healing or non-healing) are labelled, with self-transition 786 
probabilities separated by group also shown. The full transition data are also shown 787 
in Supplementary Table 3. DFU cluster designations; P = Pseudomonaceae, E = 788 
Enterobacteriaceae, C = Corynebacteriaceae, S = Staphylococcaceae, A = 789 
Anaerobes, M = Micrococcaceae. 790 
  791 
 792 
793 
Supplementary Figure 4. Additional examples of DFU profiles.  794 
Examples of DFU profiles with unexplained abrupt changes in microbial profile, or 795 
static profiles despite clinical infection. (a) Proliferation of Staphylococcus at visits 2 796 
and 9 without clinically apparent infection, (b) Transition from colonisation with 797 
Staphylococcus to Enterobacteriaceae and anaerobes at visit 6, (c) Stable 798 
colonisation with Enterobacteriaceae and Corynebacterium despite clinical infection 799 
and antibiotic exposure, (d) Colonisation with Corynebacterium unchanged by 800 
infection or antibiotic exposure, with a second episode of infection associated with 801 
proliferation of Pseudomonas. Infection, antibiotic exposure or high microbial diversity 802 
is indicated by red on the colour map, while absence of infection, antibiotic exposure 803 
or low microbial diversity is indicated by green. DFU cluster designations; P = 804 
Pseudomonaceae, E = Enterobacteriaceae, C = Corynebacteriaceae, S = 805 
Staphylococcaceae, A = Anaerobes, M = Micrococcaceae, N = Non-healing at study 806 
end, H = Healed. 807 
